A machine learning approach to predict pancreatic islet grafts rejection versus tolerance

The application of artificial intelligence (AI) and machine learning (ML) in biomedical research promises to unlock new information from the vast amounts of data being generated through the delivery of healthcare and the expanding high-throughput research applications. Such information can aid medic...

Full description

Saved in:
Bibliographic Details
Published inPloS one Vol. 15; no. 11; p. e0241925
Main Authors Ceballos, Gerardo A., Hernandez, Luis F., Paredes, Daniel, Betancourt, Luis R., Abdulreda, Midhat H.
Format Journal Article
LanguageEnglish
Published United States Public Library of Science 05.11.2020
Public Library of Science (PLoS)
Subjects
Online AccessGet full text
ISSN1932-6203
1932-6203
DOI10.1371/journal.pone.0241925

Cover

More Information
Summary:The application of artificial intelligence (AI) and machine learning (ML) in biomedical research promises to unlock new information from the vast amounts of data being generated through the delivery of healthcare and the expanding high-throughput research applications. Such information can aid medical diagnoses and reveal various unique patterns of biochemical and immune features that can serve as early disease biomarkers. In this report, we demonstrate the feasibility of using an AI/ML approach in a relatively small dataset to discriminate among three categories of samples obtained from mice that either rejected or tolerated their pancreatic islet allografts following transplant in the anterior chamber of the eye, and from naïve controls. We created a locked software based on a support vector machine (SVM) technique for pattern recognition in electropherograms (EPGs) generated by micellar electrokinetic chromatography and laser induced fluorescence detection (MEKC-LIFD). Predictions were made based only on the aligned EPGs obtained in microliter-size aqueous humor samples representative of the immediate local microenvironment of the islet allografts. The analysis identified discriminative peaks in the EPGs of the three sample categories. Our classifier software was tested with targeted and untargeted peaks. Working with the patterns of untargeted peaks (i.e., based on the whole pattern of EPGs), it was able to achieve a 21 out of 22 positive classification score with a corresponding 95.45% prediction accuracy among the three sample categories, and 100% accuracy between the rejecting and tolerant recipients. These findings demonstrate the feasibility of AI/ML approaches to classify small numbers of samples and they warrant further studies to identify the analytes/biochemicals corresponding to discriminative features as potential biomarkers of islet allograft immune rejection and tolerance.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
Current address: Center of Biomedical Engineering and Telemedicine, Faculty of Engineering, University de Los Andes, Mérida, Venezuela
Current address: Department of Morphological Sciences, Faculty of Medicine, School of Medicine, University of Los Andes, Mérida, Venezuela
Competing Interests: MHA is consultant for Biocrine, an unlisted biotech company that is using the anterior chamber of the eye technique as a research tool. This does not alter our adherence to PLOS ONE policies on sharing data and materials. All other authors declare no conflict of interest associated with their contribution to this manuscript.
ISSN:1932-6203
1932-6203
DOI:10.1371/journal.pone.0241925